These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 6335284)

  • 1. Acute lymphoblastic leukemia polymorphism disclosed by monoclonal antibodies.
    Leglise MC; Desfontaine B; Abgrall JF; Dutel JL; Le Roux AM; Vicariot M; Briere J
    Ric Clin Lab; 1984; 14(3):313-8. PubMed ID: 6335284
    [No Abstract]   [Full Text] [Related]  

  • 2. Differentiation antigens in acute leukaemia.
    Reen DJ
    Biochem Soc Trans; 1985 Apr; 13(2):420-2. PubMed ID: 3926556
    [No Abstract]   [Full Text] [Related]  

  • 3. Multimarker analysis of childhood acute lymphoblastic leukemia (ALL): heterogeneity of cellular phenotypes and clinical relevance of immunological defined ALL subclasses.
    Thoene I; Kabisch H
    Haematol Blood Transfus; 1983; 28():126-30. PubMed ID: 6574949
    [No Abstract]   [Full Text] [Related]  

  • 4. Phenotypic characterization of 'non-T, non-B' acute lymphoblastic leukemia by a new panel (BL) of monoclonal antibodies.
    Al-Katib A; Wang CY; Bardales R; Koziner B
    Hematol Oncol; 1985; 3(4):271-81. PubMed ID: 2417929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of HLA-DR alloantigens on acute lymphoblastic leukemia lymphoblasts.
    Orgad S; Yunis EJ; Zaizov R; Ramot B; Altshuler R; Gazit E
    Hum Immunol; 1984 Feb; 9(2):67-74. PubMed ID: 6421779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Abnormal phenotype of a chronic lymphatic leukemia: presence of T and B markers defined by monoclonal antibodies].
    Gómez Morales M; De Andrés MA; Garrido ML; Delgado C; Cabrera A; Garrido F
    Sangre (Barc); 1985; 30(3):348-54. PubMed ID: 3929410
    [No Abstract]   [Full Text] [Related]  

  • 7. [Acute lymphoblastic leukemia and HLA].
    Qian FW; Ye GY; Kong FH
    Zhonghua Nei Ke Za Zhi; 1986 Apr; 25(4):217-9, 253-4. PubMed ID: 3461930
    [No Abstract]   [Full Text] [Related]  

  • 8. Definition of the high-risk acute lymphoblastic leukemia patient by immunological phenotyping with monoclonal antibodies.
    Zipf TF; Fox RI; Dilley J; Levy R
    Cancer Res; 1981 Nov; 41(11 Pt 2):4786-9. PubMed ID: 6975160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA DR antigens in childhood acute lymphoblastic leukaemia long survival.
    De Bruyere M; Cornu G; Ninane J; Latinne D; Lebacq AM; Sokal G
    Br J Haematol; 1982 Aug; 51(4):659-61. PubMed ID: 6980667
    [No Abstract]   [Full Text] [Related]  

  • 10. Utility of monoclonal antibodies in the immunologic phenotyping of acute lymphoblastic leukemia.
    Yu AL; Royston I; Leung KL; Kung FH; Hartman GA; Lightsey AL; Vangrove J; Sobol RE
    Hybridoma; 1982; 1(2):91-8. PubMed ID: 6985381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A monoclonal antibody (WT1) for detecting leukemias of T-cell precursors (T-ALL).
    Vodinelich L; Tax W; Bai Y; Pegram S; Capel P; Greaves MF
    Blood; 1983 Nov; 62(5):1108-13. PubMed ID: 6354305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunological and molecular classification of acute lymphoblastic leukemia.
    Foa R; Migone N; Gavosto F
    Haematologica; 1986; 71(4):277-85. PubMed ID: 3096821
    [No Abstract]   [Full Text] [Related]  

  • 13. Human bone marrow cells positive for terminal deoxynucleotidyl transferase (TdT), HLA-DR, and a T cell marker may represent prothymocytes.
    van Dongen JJ; Hooijkaas H; Comans-Bitter M; Hählen K; de Klein A; van Zanen GE; van't Veer MB; Abels J; Benner R
    J Immunol; 1985 Nov; 135(5):3144-50. PubMed ID: 2413114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. B-lymphocyte associated differentiation antigen expression by 'non-B, non-T' acute lymphoblastic leukemia.
    Flug F; Dodson L; Wolff J; Guarini L; Rausen A; Wang CY; Knowles DM
    Leuk Res; 1985; 9(8):1051-8. PubMed ID: 2931557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ontogenic and functional implications of the differential expression of HLA-DQ antigens on leukemic cells.
    Navarrete C; Fernandez N; Alonso MC; Festenstein H
    Hum Immunol; 1986 May; 16(1):52-68. PubMed ID: 3519548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunological subclassification of non-T, non-B acute lymphoblastic leukaemia in childhood.
    Komada Y; Azuma E; Tanaka S; Ochiai H; Sakurai M
    Scand J Haematol; 1986 Jan; 36(1):85-91. PubMed ID: 2937137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell-surface structures involved in haemopoietic cell differentiation and proliferation.
    Greaves MF; Myers CD; Katz FE; Schneider C; Sutherland DR
    Br Med Bull; 1984 Jul; 40(3):224-8. PubMed ID: 6205712
    [No Abstract]   [Full Text] [Related]  

  • 18. The human T-cell leukemias: clinical, cytomorphologic, immunophenotypic, and genotypic characteristics.
    Knowles DM
    Hum Pathol; 1986 Jan; 17(1):14-33. PubMed ID: 3002948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Characteristics of the immunological subvariants of acute lymphoblastic leukemia in children].
    Baryshnikov AIu; Lenskaia RV; Kondratchik KL; Tupitsyn NN; Baĭdun LV
    Gematol Transfuziol; 1987 Feb; 32(2):26-31. PubMed ID: 3493944
    [No Abstract]   [Full Text] [Related]  

  • 20. HLA-DR antigens on CLL lymphocytes.
    Johnstone AP
    Br J Haematol; 1982 Feb; 50(2):378-9. PubMed ID: 6977375
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.